# Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial.

> **NCT05920512** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xue-chun Lu** · enrollment: 10 (estimated)

## Conditions studied

- Hemophilia

## Interventions

- **DRUG:** Sodium valproate extended-release tablets

## Key facts

- **NCT ID:** NCT05920512
- **Lead sponsor:** Xue-chun Lu
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05920512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05920512, "Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05920512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*